S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
BABA   222.14 (+0.73%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
T   38.44 (+0.47%)
ACB   1.71 (+4.27%)
F   8.00 (-0.74%)
NFLX   386.19 (-0.41%)
PRI   135.69 (+0.05%)
BAC   34.72 (+1.31%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

ADMA Biologics SEC Filings & 10K Form (NASDAQ:ADMA)

$3.87
+0.16 (+4.31 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
$3.60
Now: $3.87
$3.94
50-Day Range
$3.32
MA: $4.01
$4.58
52-Week Range
$3.03
Now: $3.87
$6.31
Volume2.45 million shs
Average Volume1.45 million shs
Market Capitalization$229.56 million
P/E RatioN/A
Dividend YieldN/A
Beta2.62

SEC Filings

ADMA Biologics (NASDAQ:ADMA) SEC Filings

DateFilerForm TypeView
02/14/2020
11:17 AM
ADMA Biologics (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
02/13/2020
4:27 PM
ADMA Biologics (Subject)
Broadfin Capital, LLC (Filed by)
Form SC 13G/A
02/11/2020
9:18 AM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:16 AM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:15 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:13 AM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
9:11 AM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
7:02 AM
ADMA Biologics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
6:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2020
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
4:18 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
6:18 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
4:29 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
4:11 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
6:58 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
6:58 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2019
6:49 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
11:15 PM
ADMA Biologics (Filer)
Form EFFECT
10/07/2019
3:11 PM
ADMA Biologics (Filer)
Form 424B7
10/07/2019
6:28 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2019
4:01 PM
ADMA Biologics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/03/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2019
6:38 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2019
7:08 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
6:29 AM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
6:08 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
3:48 PM
ADMA Biologics (Filer)
Form DEF 14A
07/08/2019
3:45 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
4:00 PM
ADMA Biologics (Filer)
Form PRE 14A
06/11/2019
7:22 PM
ADMA Biologics (Filer)
Form 8-K/A
06/07/2019
3:26 PM
ADMA Biologics (Subject)
Biotest Divestiture Trust (Filed by)
Form SC 13D/A
06/07/2019
3:25 PM
ADMA Biologics (Issuer)
Biotest Divestiture Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
5:01 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2019
6:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
7:32 AM
ADMA Biologics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2019
7:31 AM
ADMA Biologics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
05/21/2019
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
6:14 AM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
6:13 AM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
6:12 AM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
6:12 AM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
6:11 AM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
3:16 PM
ADMA Biologics (Filer)
Form 424B5
05/17/2019
6:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
4:14 PM
ADMA Biologics (Filer)
Form 424B5
05/15/2019
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
6:05 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
4:11 PM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2019
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2019
6:00 AM
ADMA Biologics (Filer)
Form DEF 14A
04/17/2019
6:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2019
2:53 PM
ADMA Biologics (Filer)
Form CT ORDER
04/05/2019
4:01 PM
ADMA Biologics (Filer)
Form PRE 14A
04/01/2019
8:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
6:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
4:02 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
4:01 PM
ADMA Biologics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
4:01 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
4:01 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
4:00 PM
ADMA Biologics (Issuer)
RICHMAN ERIC I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
4:00 PM
ADMA Biologics (Issuer)
Fong Bryant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
4:17 PM
ADMA Biologics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2019
4:05 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
6:09 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
4:08 PM
ADMA Biologics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2019
7:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
6:43 AM
ADMA Biologics (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G/A
02/12/2019
6:47 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2019
4:15 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2019
8:31 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
8:31 PM
ADMA Biologics (Issuer)
Mond James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
8:30 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2019
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2018
3:41 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2018
10:58 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
4:10 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2018
6:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2018
8:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2018
4:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2018
11:00 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2018
2:27 PM
ADMA Biologics (Filer)
Form CT ORDER
09/05/2018
6:31 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
6:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2018
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
6:31 AM
ADMA Biologics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2018
6:20 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
3:33 PM
ADMA Biologics (Subject)
Biotest Divestiture Trust (Filed by)
Form SC 13D
08/09/2018
3:33 PM
ADMA Biologics (Issuer)
Biotest Divestiture Trust (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
3:32 PM
ADMA Biologics (Issuer)
Biotest Divestiture Trust (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/03/2018
3:00 PM
ADMA Biologics (Subject)
Biotest AG (Filed by)
Form SC 13D/A
07/26/2018
10:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2018
7:15 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2018
4:01 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2018
3:45 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel